Fourth-quarter 2013 worldwide sales of $5.

Abbott is focused on 14 Important Emerging Markets that represent attractive long-term growth opportunities. Sales in these Key Emerging Markets increased 10.1 % on an operational basis in the quarter, led by solid growth in Brazil, China and Russia. Reported sales, which include an unfavorable aftereffect of 7.4 % of foreign exchange, increased 2.7 % in the quarter. Other Markets include developed markets, such as Western Europe and Japan, and other emerging marketplaces globally. Sales in these geographies decreased 6.7 % in the quarter on an operational basis and 9.8 % on a reported basis, including an unfavorable 3.1 % effect of foreign exchange. Needlessly to say, sales growth in developed markets continues to be impacted by market conditions, in Western Europe particularly.Specifically, ASTRO is definitely grateful for the tremendous leadership of Reps. Lois Capps , Sue Myrick , Mike Rogers and Parker Griffith and Sens. Blanche Lincoln and Richard Burr for spearheading efforts to avoid the proposed cuts. Letters from Congress, ASTRO comment letters and other components on the cuts are available at SOURCE American Culture for Radiation Oncology.. AVTD freezes its EOS device design for regulatory phase ArtVentive Medical Group, Inc. announced today that the business provides frozen its Endoluminal Occlusion device style for the peripheral category of indications in preparation for the business’s regulatory phase, ahead of commercialization in North and European countries America and subsequent to venturing forward into Eastern Europe, Japan, Asia Pacific and Latin America.